Endonovo Therapeutics, Inc. (ENDV) bonds
ENDVOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2023, quý kết thúc ngày Sep 30, 2023Last filing: 10-Q/A on Dec 29, 2023
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $135.08KP/E –Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2023
Endonovo Therapeutics reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
When the debt comes due
Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2022
From the debt maturity table in the annual report (filing). “Later” is everything due after year five.
Notes and loans outstanding
As tagged in Endonovo Therapeutics's 10-Q for the period ended Sep 30, 2023
| Issue | Coupon | Amount issued | Carrying value |
|---|---|---|---|
| Eight Fixed Promissory Notes | 15.00% | – | $950.00K |
| Eighteen Fixed Rate | – | $1.47M | – |
| Eighteen Fixed Rated Notes | – | – | $1.92M |
| Fixed Rate Notes | – | – | $1.85M |
| Fixed Rated Notes | – | – | $1.84M |
| Fourteen Fixed Rated Notes | – | $1.40M | – |
| One Promissory Notes | – | – | $465.00K |
| One Variable Note | – | $163.83K | – |
| Sixteen Fixed Rated Notes | – | – | $1.89M |
| Three Fixed Rated Notes | 15.00% | – | – |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
See a number that looks wrong?